Boule Diagnostics Balance Sheet Health
Financial Health criteria checks 2/6
Boule Diagnostics has a total shareholder equity of SEK313.0M and total debt of SEK195.8M, which brings its debt-to-equity ratio to 62.6%. Its total assets and total liabilities are SEK643.5M and SEK330.5M respectively. Boule Diagnostics's EBIT is SEK41.8M making its interest coverage ratio 8. It has cash and short-term investments of SEK40.5M.
Key information
62.6%
Debt to equity ratio
SEK 195.80m
Debt
| Interest coverage ratio | 8x |
| Cash | SEK 40.50m |
| Equity | SEK 313.00m |
| Total liabilities | SEK 330.50m |
| Total assets | SEK 643.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BOULS's short term assets (SEK263.8M) do not cover its short term liabilities (SEK273.1M).
Long Term Liabilities: BOULS's short term assets (SEK263.8M) exceed its long term liabilities (SEK57.4M).
Debt to Equity History and Analysis
Debt Level: BOULS's net debt to equity ratio (49.6%) is considered high.
Reducing Debt: BOULS's debt to equity ratio has increased from 28.6% to 62.6% over the past 5 years.
Debt Coverage: BOULS's debt is not well covered by operating cash flow (6.9%).
Interest Coverage: BOULS's interest payments on its debt are well covered by EBIT (8x coverage).